I set sail on the pinnacle
Release time:
2020-08-14
I set sail at the peak
■ peak health should be super handsome
I am a native of Jinhua and have had different feelings for the peak since I was a child. In junior high school, every time I went to and from school, I always passed by the Peak Building. At that time, Jinhua did not have so many tall buildings. The Peak Building standing by the Wujiang River always attracted my attention. At that time, I thought that I must enter this unit to work after graduation. Time flies, and when I graduated from university in 2016 , I threw my first resume at the peak, and the peak also extended an olive branch to me. Unconsciously, I have spent two years in the peak, and from an ignorant graduate to a peak employee who can make a difference in his work.
When I first arrived at Jianfeng Health Technology Company, I was assigned to practice in the Health Products Division. At that time, I not only didn't know how to be a qualified sales back office worker, but also didn't know how to use ERP to ship orders and register sales ledgers. Fortunately, I met a group of enthusiastic colleagues. At that time, Xu Yuting, who was in the same office, I called her "Xu Jie" and asked her for advice every time I encountered problems. At that time, I thought that it would be nice if I could know everything like her. Later, I learned that she had entered the peak after graduating from college and had been tempered in many different positions such as quality management, marketing, and sales. I secretly made up my mind that I could not meet the status quo and would try my best to improve my professional quality.
2016 7 February, I bid farewell to my first post after graduation and transferred to the finance department. Although the financial office is opposite the original office, my nose is still sour when moving things, and I am reluctant to part with it. The job of finance is familiar and unfamiliar to me, because I studied accounting in college, but I have never actually operated it. I remember that at that time, the company had the "Measures for the Training and Assessment of College Graduates", which included the training requirements of "teachers and apprentices". Therefore, I also had an instructor-Bao Jieming, deputy manager of the finance department. Manager Bao used to work in a pharmaceutical company, not only experienced and rigorous, but also very strict with me, from how to bind a neat voucher, how to standardize the summary of the voucher, how to write the correct accounting entries to the preparation of financial statements, everything should be perfect. I remember one time when the statement was prepared, the net profit accumulated on the income statement for the current year did not match the number of undistributed profits on the balance sheet for the current period, which he saw at a glance when reviewing the statement. I still remember what he said at the time, "It is necessary to be careful in finance. If such a wrong statement is submitted, it will cause trouble to the leadership's decision-making and the group company's consolidated statement, and the consequences will be very serious!" Since then, I have required myself to do a good job of checking between the statements and the statements, and between the statements and the books of account, so as to be accurate.
2017 , the peak health management structure was adjusted, and the finance department and the comprehensive department were merged into the comprehensive finance department. not only did the department leaders need to manage two types of work at the same time, but sometimes our staff also had to coordinate and help each other, which was also a challenge for the finance personnel. Several times I went out to recruit, but the office was short of staff. The leader asked me to follow. To be honest, I really don't know anything about recruitment. I 've only been recruited by others before, and I'm not used to changing my status all of a sudden. From going out to recruit again and again, with the help and guidance of my colleagues, I learned how to introduce my enterprise generously, how to ask questions and answer candidates, and how to identify whether it is the talents needed by the enterprise. These are all new knowledge to me.
In 2017 , due to the resignation of some colleagues, although the financial work was relatively busy at that time, I was obliged to accept this "part-time job". Because the problems encountered by network management are temporary, I don't know when problems will occur. Whenever the phone rings and informs the company of network problems, I will arrive in time to help solve them. Not long after I took over this "part-time job", one day the company suddenly cut off the Internet at noon, and the office phone and my mobile phone rang one after another, which made me very nervous. After answering the phone, the first thought in my heart was to eliminate this network failure. I took a deep breath, calmed down, and then began to find the source of the problem. After many investigations, I finally found that a router in the workshop had malfunctioned, resulting in all the computers in the company being assigned to the wrong IP address. After resetting the router, the network returned to normal, and I was relieved.
In the two years of peak, I have gradually matured from my ignorance and ignorance. In this big family, I deeply feel the strength of unity and mutual assistance. The peak has given me more motivation to grow up. In the days to come, I will still be grateful, take every step steadily, and set sail here!
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31